Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-24-000011

Chief Medical Officer acquired 94,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Siemers Eric Chief Medical Officer 2024-01-02 Grant or award +94,000 120,700 D
Derivatives
Siemers Eric Chief Medical Officer 2024-01-02 Grant or award · Employee Stock Option (right to buy) +141,000 141,000 D
Loading xslF345X05/wk-form4_1704403255.xml…